To include your compound in the COVID-19 Resource Center, submit it here.

EC approves Opdivo plus Yervoy combo for RCC

The European Commission accepted for review a Type II variation from Bristol-Myers Squibb Co. (NYSE:BMY) to expand

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE